TGA maintain cautious approach to testosterone replacement therapy

Testosterone replacement therapy should only be prescribed to men who have confirmed testosterone deficiency, and any patient eligible for treatment must also be warned about potential cardiovascular risks, the TGA has said. In a medicines safety update, the TGA says it has received adverse event reports associated with off-label use particularly among ageing men who ...

Already a member?

Login to keep reading.

© 2022 the limbic